SPARCL1 and pulmonary arterial hypertension: Moreover, four ECM proteins were enough to significantly predict early versus late stages of RV decompensation in PAH participants, which is in line with less significant changes in SPARCL1 protein levels both in plasma and RV (Fig. 8n).